Q BioMed Inc (OTCQB: $QBIO) to Present at the Global Chinese Financial Forum on April 30, 2016

Toronto, ON Conference Expects to Attract Over 200 Participants

NEW YORK - April 26, 2016 (Investorideas.com Newswire) Q BioMed Inc. (OTC: QBIO), a biotechnology acceleration company, today announced that the company will present at the Global Chinese Financial Forum (GCFF). The GCFF is the most prominent series of bi-lingual financial functions in both North America and China. Established in 2000, GCFF's mandate is to provide a world-class platform connecting both the Asian and North American financial markets. GCFF assembles companies, financial institutions and investors who are interested in exploring new investment ideas and financial opportunities.

The conference is being held at the Marriott Courtyard Hotel in Markham, Ontario Canada at 7095 Woodbine Ave, Markham, Ontario.

The conference runs from 9am to 5pm. Q BioMed CEO, Denis Corin, will present at 10:20am.

Organizers expect the conference to attract over 200 participants consisting of pre-qualified investors, industry executives and professional service providers.

For more information or to register as an attendee of the conference, please click HERE.

To stay informed on Q BioMed developments please visit our website http://www.qbiomed.com and sign up for our news distribution.

Read this release in full at http://www.investorideas.com/CO/QBIO/news/2016/04261.asp

About GCFF - GLOBAL CHINESE FINANCIAL FORUM

Organized by NAI Interactive, the Global Chinese Financial Forum (GCFF) is the most prominent series of bi-lingual financial functions in both North America and China. Established in 2000, GCFF's mandate is to provide a world-class platform connecting both the Asian and North American financial markets. We assemble companies, financial institutions and investors who are interested in exploring new investment ideas and financial opportunities.

With an extensive network covering both the North American and Chinese market alongside expertise in the global capital market, GCFF is supported by a strong foundation of financial resources. It enables GCFF to organize resourceful financial events that facilitate business growth and networks among financial institutions, public corporations, private companies, and investors of all levels.

In the past 16 years, over 35 GCFF conferences have been held in multiple locations worldwide including Vancouver, Toronto and China. The latest LNG Investment Conference was held in April 2014 to enlighten the Chinese community on the latest LNG development in British Columbia. The conference attracted over 200 participants consisting of pre-qualified investors, industry executives and professional service providers.

About Q BioMed Inc.

Q BioMed Inc. ”Q“ is a biomedical acceleration and development company. We are focused on acquiring companies and biomedical assets. Q is dedicated to providing these target companies and assets, strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need.

Forward-Looking Statements:

This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Contact:

Denis Corin

CEO

Q BioMed Inc.

1 888 357 2435 

 

Visit this Company: http://www.qbiomed.com

 

More info on QBIO at Investorideas.com: http://www.investorideas.com/CO/QBIO/

 

Sign up for the free investor news and stock alerts:

http://www.investorideas.com/Resources/Newsletter.asp

 

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Disclosure: QBIO has retained investorideas.com for PR, media, news publication and social media effective February 5th for three months: two thousand five hundred per month.

 

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:

http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.